SETD2 and lung adenocarcinoma: SETD2-deficient cells display a robust tumor-driver property 41, functional loss of SETD2 and lower expression of H3K36me3 accelerate the progression of both early- and late-stage lung adenocarcinoma (LUAD), and such situation may be associated with deficiency of SWI/SNF complex 87.